HRT FINANCIAL LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1475597 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,025,701

+$5,802,215 QoQ

Shares Held

295,918

+111.0% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#150

of 671 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $132,018,408 across 28 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	98,864	$53,567,481
2	ZTS	Zoetis Inc.	241,369	$17,344,776
3	BCRX	Biocryst Pharmaceuticals Inc	1,081,523	$10,815,230
4	TEVA	Teva Pharmaceutical Industries Ltd This page	295,918	$10,025,701
5	AMPH	Amphastar Pharmaceuticals, Inc.	387,530	$7,820,355
6	HLN	Haleon plc	682,281	$6,365,681
7	ANIP	Ani Pharmaceuticals Inc	63,008	$5,215,802
8	TAK	Takeda Pharmaceutical Co Ltd	278,706	$4,467,657

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,025,701	295,918	+111.0%	Shares	Defined	2026-08-14
2026-03-31	$4,223,486	140,222	+998.5%	Shares	Defined	2026-05-14
2025-12-31	$398,395	12,765	-61.0%	Shares	Defined	2026-02-12
2023-09-30	$333,652	32,711	-25.6%	Shares	Defined	2023-11-13
2023-06-30	$331,214	43,986	+42.1%	Shares	Defined	2023-08-11
2023-03-31	$273,987	30,959	-10.1%	Shares	Defined	2023-05-12
2022-06-30	$258,891	34,427	+32.7%	Shares	Defined	2022-08-12
2021-06-30	$256,845	25,944	-25.5%	Shares	Defined	2021-08-16
2021-03-31	$401,695	34,809	+86.3%	Shares	Defined	2021-05-17
2020-12-31	$180,329	18,687	+16.0%	Shares	Defined	2021-02-16
2020-03-31	$144,622	16,105	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.